4//SEC Filing
Gurrola Sandra M 4
Accession 0001140361-22-023928
CIK 0000748592other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:31 PM ET
Size
8.2 KB
Accession
0001140361-22-023928
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Exercise/Conversion
Common Stock
2022-06-21+8,750→ 16,953 total - Tax Payment
Common Stock
2022-06-21$0.48/sh−3,586$1,709→ 13,367 total - Exercise/Conversion
Restricted Stock Units
2022-06-21−8,750→ 26,250 total→ Common Stock (8,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001618457
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:31 PM ET
- Size
- 8.2 KB